1. Epidemiología del melanoma en el Instituto Nacional de Cancerología, 2006-2010;Pozzobon,2012
2. Genotipificación del Melanoma en Colombia;Carranza;Rev Colomb Hematol Oncol.,2013
3. BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: A potential neoadjuvant strategy;Sloot;Melanoma Res.,2016
4. Roche. Assesment report - Zelboraf (Vemurafeninb), ema.europa.eu; 2011 [consultado 24 Mar 2016]. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002409/WC500124400.pdf
5. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 19:3622-34.